
Nutrien Ltd. (NYSE:NTR - Free Report) - Equities researchers at Zacks Research dropped their Q2 2025 earnings per share (EPS) estimates for shares of Nutrien in a research report issued to clients and investors on Monday, July 28th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $2.25 per share for the quarter, down from their previous forecast of $2.26. The consensus estimate for Nutrien's current full-year earnings is $3.72 per share. Zacks Research also issued estimates for Nutrien's Q3 2025 earnings at $0.59 EPS, Q4 2025 earnings at $0.53 EPS, FY2025 earnings at $3.43 EPS, Q2 2026 earnings at $1.35 EPS, Q3 2026 earnings at $0.92 EPS, Q4 2026 earnings at $1.03 EPS, FY2026 earnings at $3.57 EPS, Q1 2027 earnings at $0.69 EPS, Q2 2027 earnings at $1.17 EPS and FY2027 earnings at $3.73 EPS.
Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.24). The company had revenue of $4.67 billion during the quarter, compared to analyst estimates of $5.16 billion. Nutrien had a net margin of 2.05% and a return on equity of 6.08%. Nutrien's revenue was down 5.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.46 earnings per share.
Several other equities analysts have also recently weighed in on the company. UBS Group lifted their price objective on Nutrien from $56.00 to $64.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. Barclays boosted their price target on Nutrien from $61.00 to $64.00 and gave the stock an "equal weight" rating in a report on Monday, July 7th. Berenberg Bank boosted their price target on Nutrien from $54.00 to $59.00 and gave the stock a "buy" rating in a report on Tuesday, April 15th. Scotiabank cut Nutrien from an "outperform" rating to a "sector perform" rating and set a $62.00 price target for the company. in a report on Thursday, May 22nd. Finally, Oppenheimer boosted their price target on Nutrien from $63.00 to $65.00 and gave the stock an "outperform" rating in a report on Tuesday, July 15th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $63.22.
Get Our Latest Stock Analysis on Nutrien
Nutrien Price Performance
NYSE NTR traded down $0.02 during midday trading on Wednesday, hitting $59.33. The company had a trading volume of 1,857,866 shares, compared to its average volume of 1,622,852. The company has a market capitalization of $28.89 billion, a PE ratio of 55.45, a P/E/G ratio of 1.09 and a beta of 0.80. The company has a current ratio of 1.22, a quick ratio of 0.59 and a debt-to-equity ratio of 0.41. The firm has a 50-day moving average price of $60.12 and a 200-day moving average price of $55.11. Nutrien has a twelve month low of $43.69 and a twelve month high of $65.08.
Nutrien Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, July 18th. Shareholders of record on Monday, June 30th were issued a dividend of $0.545 per share. The ex-dividend date was Monday, June 30th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 3.7%. Nutrien's dividend payout ratio is 203.74%.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in NTR. Wealth Enhancement Advisory Services LLC boosted its position in shares of Nutrien by 184.1% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 12,243 shares of the company's stock worth $608,000 after purchasing an additional 7,934 shares in the last quarter. Farther Finance Advisors LLC boosted its position in shares of Nutrien by 27.6% in the 1st quarter. Farther Finance Advisors LLC now owns 4,627 shares of the company's stock worth $229,000 after purchasing an additional 1,002 shares in the last quarter. Kingswood Wealth Advisors LLC bought a new stake in shares of Nutrien in the 1st quarter worth approximately $517,000. Bessemer Group Inc. boosted its position in shares of Nutrien by 163.7% in the 1st quarter. Bessemer Group Inc. now owns 1,690 shares of the company's stock worth $84,000 after purchasing an additional 1,049 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Nutrien by 4,866.7% in the 1st quarter. GAMMA Investing LLC now owns 1,043 shares of the company's stock worth $52,000 after purchasing an additional 1,022 shares in the last quarter. Hedge funds and other institutional investors own 63.10% of the company's stock.
Nutrien Company Profile
(
Get Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
See Also

Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.